MedTrace Logo

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

NCT06528444 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-02-19

No results posted yet for this study

Summary

Clinical trial with an active ingredient of a pharmaceutical specialty marketed in Spain vs. placebo.

Randomized, double-blind, multicenter phase III clinical trial that evaluates the efficacy and safety of dexamethasone compared to placebo in patients with severe influenza.

Conditions

Interventions

DRUG

Grup 1 placebo

placebo 1 capsule (6 mg) /day for 7 days.

DRUG

Grup 2 dexametasona

dexamethasone 1 capsule (6 mg)/day for 7 days

Sponsors & Collaborators

  • Instituto de Investigación Sanitaria y Biomédica de Alicante

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06528444 on ClinicalTrials.gov